about
Polypoidal choroidal vasculopathy: an angiographic discussion.Polypoidal Choroidal Vasculopathy with Feeder Vessels: Characteristics, Fellow Eye Findings, and Long-term Treatment Outcomes.Associations of complement factor B and complement component 2 genotypes with subtypes of polypoidal choroidal vasculopathy.Three major loci involved in age-related macular degeneration are also associated with polypoidal choroidal vasculopathy.Time-lag between subretinal fluid and pigment epithelial detachment reduction after polypoidal choroidal vasculopathy treatmentOutcome of polypoidal choroidal vasculopathy at 1 year by combined therapy of photodynamic therapy with ranibizumab and predictive factors governing the outcome.The noninvasive retro-mode imaging modality of confocal scanning laser ophthalmoscopy in polypoidal choroidal vasculopathy: a preliminary application.The association of elastin gene variants with two angiographic subtypes of polypoidal choroidal vasculopathy.Automatic Segmentation of Polypoidal Choroidal Vasculopathy from Indocyanine Green Angiography Using Spatial and Temporal Patterns.Increased expression of multifunctional serine protease, HTRA1, in retinal pigment epithelium induces polypoidal choroidal vasculopathy in mice.En face imaging of the choroid in polypoidal choroidal vasculopathy using swept-source optical coherence tomography.Difference between age-related macular degeneration and polypoidal choroidal vasculopathy in the hereditary contribution of the A69S variant of the age-related maculopathy susceptibility 2 gene (ARMS2).Clinical characteristics of polypoidal choroidal vasculopathy associated with chronic central serous chorioretionopathyEffect of High-Density Lipoprotein Metabolic Pathway Gene Variations and Risk Factors on Neovascular Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy in China.Polypoidal choroidal vasculopathy appearing as classic choroidal neovascularisation on fluorescein angiographyCombined argon laser photocoagulation and antivascular endothelial growth factor for management of macular polypoidal choroidal vasculopathyOne-year outcome of intravitreal aflibercept injection for age-related macular degeneration resistant to ranibizumab: rapid morphologic recovery and subsequent visual improvement.Evaluating Polypoidal Choroidal Vasculopathy With Optical Coherence Tomography AngiographyChoroidal venous pulsations at an arterio-venous crossing in polypoidal choroidal vasculopathy.Coding variant Met72Thr in the PEDF gene and risk of neovascular age-related macular degeneration and polypoidal choroidal vasculopathy.SOD2 gene polymorphisms in neovascular age-related macular degeneration and polypoidal choroidal vasculopathy.Comparison of the 1-year Outcomes of Conbercept Therapy between Two Different Angiographic Subtypes of Polypoidal Choroidal Vasculopathy.Five-year results of photodynamic therapy with verteporfin for Japanese patients with neovascular age-related macular degeneration.ENOS polymorphisms in neovascular age-related macular degeneration and polypoidal choroidal vasculopathy in a Chinese Han population.The natural history of polypoidal choroidal vasculopathy: a multi-center series of untreated Asian patients.Prognostic phenotypic and genotypic factors associated with photodynamic therapy response in patients with age-related macular degeneration.Polypoidal choroidal vasculopathy with an appearance similar to classic choroidal neovascularisation on fluorescein angiography.Indocyanine green angiographic and optical coherence tomographic findings support classification of polypoidal choroidal vasculopathy into two types.Polypoidal choroidal vasculopathy examined with en face optical coherence tomography.Morphologic Criteria of Lesion Activity in Neovascular Age-Related Macular Degeneration: A Consensus Article.Understanding aneurysmal type 1 neovascularization (polypoidal choroidal vasculopathy): a lesson in the taxonomy of 'expanded spectra' - a review.Comparison of indocyanine green angiography and optical coherence tomographic angiography in polypoidal choroidal vasculopathy.Comparison of swept source optical coherence tomography and spectral domain optical coherence tomography in polypoidal choroidal vasculopathy.Factors associated with polyp regression after intravitreal ranibizumab injections for polypoidal choroidal vasculopathy.En-face high-penetration optical coherence tomography imaging in polypoidal choroidal vasculopathy.Three-year follow-up results of photodynamic therapy for polypoidal choroidal vasculopathy.Prognostic factors of 2-year outcomes of ranibizumab therapy for polypoidal choroidal vasculopathy.Comparison of the effects of photodynamic therapy, intravitreal ranibizumab and combination for polypoidal choroidal vasculopathy under 1 + PRN regimen.
P2860
Q33523990-B77A45E0-CE6E-4117-9E92-8059304F8AB1Q33794644-658BACE1-D146-4A71-9110-F397C4CFE881Q33825723-9AADE0D3-C754-4A0F-88A3-B361275D4D00Q33982669-7A4E0895-45F3-4C71-96D2-752B1FAA6931Q34695085-2F718ED2-FB8B-4D17-BF84-B7246DF272DEQ34718477-58B0382C-F417-4B55-BCE4-5C5A7C297B96Q34995133-1F4C9027-DF58-4982-A951-C01AA22E99ADQ35182156-37A100AF-E4B6-4826-845E-C4E365333CE1Q35190854-B926FFC3-4621-4639-BF60-F8CE0AD6BA83Q35197893-400CFC64-8FC9-42CE-B168-F3928CB7273BQ35289120-243A169A-743B-47AC-A102-4E240EBC7FA0Q35648440-D747136D-D202-4C6B-B92D-C2060E751F11Q35707962-2B035FDE-C99B-4C60-9B36-8254BE4FBB3EQ35857083-39A42B2F-7890-49E9-A74B-A48B21A846C0Q35954073-E74A311D-77BE-4CDC-8909-2FD568A02B7BQ36192272-24BF4494-F816-4789-BE2B-80843E33C2B6Q36955686-0F75ECAE-091B-4FB2-A85C-82D0933D9E6FQ37146642-0C372695-69D9-4A18-AECA-44F857CC7498Q37196200-04E1E93F-8B04-4A55-B537-63F6FE8125D7Q37213669-060414FF-5298-43AF-BD4D-38808E6A84A9Q37343506-926867CC-C6DD-4A9D-BFAB-D356C40599E5Q37445392-22B0E5B9-CCAD-468E-BAF0-195B9341A7F7Q39568542-61D146E2-C00D-4239-A3B7-F689286C89B9Q39969151-78F01290-7FD6-4CB0-9D09-DD6C30296746Q41529588-6024C25E-C426-43B4-AE4F-B8C004FBFBB8Q41995683-59B8592F-3212-41D5-9D64-8D86067FCC93Q42410067-FE02E1F1-BB5D-4A37-BB48-12F64910DDE8Q43947509-52E09BC4-EDA5-4D67-8C87-C7A9E9A0F33DQ46982415-7EB7B970-B231-4D85-BF49-0E48CDA38746Q47606173-764E7093-B176-4368-89BC-F4B848C7763CQ48232207-EEA4A3A5-2C5B-493C-A9E4-00B3D2BA17D1Q50215784-2E382CD3-06DB-49F5-9F0F-A28EEAD76971Q50259529-B72971B5-5A97-4B1E-8B96-2B16C0C94BC8Q50446492-7010C10B-E0AC-4AB6-AEBA-F913AC748D8BQ50451489-24AEBA00-BA75-4ABB-8216-C4C4C94000E5Q50526503-70B41136-3ABD-47B8-91CB-2682215EA2D1Q53675303-65BDCD75-7765-4410-B9EA-16466A3FBE8AQ55431176-15BF6865-41C4-4555-B5CE-234FE8A39B7C
P2860
description
2005 nî lūn-bûn
@nan
2005 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
The origins of polypoidal choroidal vasculopathy
@ast
The origins of polypoidal choroidal vasculopathy
@en
type
label
The origins of polypoidal choroidal vasculopathy
@ast
The origins of polypoidal choroidal vasculopathy
@en
prefLabel
The origins of polypoidal choroidal vasculopathy
@ast
The origins of polypoidal choroidal vasculopathy
@en
P2093
P2860
P356
P1476
The origins of polypoidal choroidal vasculopathy
@en
P2093
P2860
P304
P356
10.1136/BJO.2004.049296
P407
P577
2005-05-01T00:00:00Z